The Drug Trial Betting Market Has a Dirty Secret: It Needs Insider Trading to Work
Prediction markets on drug trials promise to reveal the truth before official results. But there’s a catch: they only work if insiders can trade on non-public data—which is illegal. The SEC and FDA are heading for a collision that will decide whether these markets become life-saving tools or just sophisticated casinos.